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The colonic human MUC2 mucin forms a polymeric gel by
covalent disulﬁde bonds in its N- and C-termini. The middle
part of MUC2 is largely composed of two highly O-glycosylated
mucindomainsthatareinterruptedbyaCysDdomainofunknown
function. We studied its function as recombinant proteins
fused to a removable immunoglobulin Fc domain. Analysis of
afﬁnity-puriﬁed fusion proteins by native gel electrophoresis and
gel ﬁltration showed that they formed oligomeric complexes.
Analysis of the individual isolated CysD parts showed that they
formed dimers both when ﬂanked by two MUC2 tandem repeats
andwithoutthese.Cleavagesofthetwonon-reducedCysDfusion
proteins and analysis by MS revealed the localization of all ﬁve
CysD disulﬁde bonds and that the predicted C-mannosylated site
was not glycosylated. All disulﬁde bonds were within individual
peptidesshowingthatthedomainwasstabilizedbyintramolecular
disulﬁde bonds and that CysD dimers were of non-covalent
nature. These observations suggest that CysD domains act as
non-covalent cross-links in the MUC2 gel, thereby determining
the pore sizes of the mucus.
Keywords:C-mannosylation,disulﬁdebonds,massspectrometry
(MS), mucus, non-covalent dimer.
INTRODUCTION
Mucins are large glycoproteins that coat the surfaces of cells
in the respiratory, digestive and urogenital tracts, and, in some
amphibia, the skin [1,2]. They function to protect epithelial cells
from infection, dehydration and physical injury, as well as to
aid passage of materials on mucosal surfaces. The mucins have
mucin domains with large amounts of O-linked oligosaccharides
attached on the protein sequence rich in proline, threonine and
serine (PTS domain) [3]. Moreover, these domains often have
tandemly repeated amino acid sequences that vary in number,
length and sequence in different mucins [3]. There are two
types of mucins, membrane-bound and secreted. In humans, six
secretedmucinshavebeenconﬁrmed;thegel-formingMUC2[4],
MUC5AC [5], MUC5B [6], MUC6 [7] and MUC19 [8], and the
non-gel forming MUC7 [9].
MUC2 is the major gel-forming mucin of the colon and
organizes the mucus into two layers, an inner densely packed
layer and an outer loosely adherent layer that is colonized by
bacteria[10].MUC2containsﬁvedistinctregions(Figure1A):an
N-terminal part with von Willebrand D1-D2-D
 -D3 domains and
a CysD domain, a small PTS domain, another CysD domain, a
large PTS (tandem-repeated) domain, and a C-terminal part with
vonWillebrandD4-B-CdomainsandaCK(cystine-knot)domain
[4]. MUC2 forms disulﬁde-linked dimers via its C-terminal parts
in the endoplasmic reticulum [11,12] and disulﬁde-linked trimers
via its N-terminal part in the trans-Golgi network [13]. The
concerted C-terminal dimerization and N-terminal trimerization
ofMUC2monomersleadstotheassemblyofapolymericnet-like
structure that can bind water via its heavily O-glycosylated mucin
domains to form a gel. Although the von Willebrand domains and
CK domain are involved in polymer formation, the function of
the CysD domains remains elusive. Interestingly, multiple CysD
domains have also been identiﬁed in other human gel-forming
mucins, in MUC5AC [14] and MUC5B [15] respectively. The
small 110-residue-long CysD domains with ten invariant cysteine
residues are found adjacent to or scattered within the heavily
O-glycosylated central region of these mucins, at least nine in
MUC5AC and seven in MUC5B. It is worth noting that the genes
for human gel-forming mucins MUC2, MUC5AC and MUC5B
are localized to the same chromosome locus, 11p15.5 [16].
The high intra- and inter-species homologies suggest that the
CysD domains play critical, but as yet undeﬁned, roles in mucus
homoeostasis.MucinCysDdomainsshowsigniﬁcanthomologies
with a protein domain in human cartilage, intermediate layer
protein [17], and with a protein domain in the protein Oikosin
1 of the larvacean tunicate Oikopleura dioica [18]. Neither the
tertiary structure nor the speciﬁc functions of these two proteins
areknown,althoughithasbeenproposedthattheyhavestructural
roles in the organization of articular cartilage and the larvacean
mucous houses respectively. A potential C-mannosylation
WXXW acceptor site [19] is found in the CysD domains of
MUC2, MUC5AC and MUC5B, and in 11 repeats in Oikosin 1.
It has been suggested that at least the CysD1 and CysD5 domains
of MUC5AC are mannosylated [20]. Moreover, Perez-Vilar et al.
[20] reported that the CysD domains CysD1 and CysD5 of
MUC5AC and CysD1 and CysD3 of MUC5B were monomers.
The mucin domains of different mucins are similar in sequence
and the localization of the cysteine residues are identical (see
http://www.medkem.gu.se/mucinbiology/databases/index.html).
More recently, we found the CysD domain in a number of
gel-forming mucins from other species such as mammals, frog,
ﬁsh, fruit ﬂy, sea urchin, sea squirt and lancelet respectively [3].
We therefore aimed at studying the function and biochemical
properties of the CysD domain. We chose to analyse the second
CysDdomainofhumanMUC2.Tworecombinantfusionproteins
Abbreviations used: AGC, automatic gain control; BN-PAGE, blue native PAGE; CHO, Chinese-hamster ovary; CID, collision-induced dissociation;
CK domain, cystine-knot domain; EK, enterokinase; ESI, electrospray ionization; FBS, fetal bovine serum; IMDM, Iscove’s modiﬁed Dulbecco’s medium;
LC, liquid chromatography; mAb, monoclonal antibody; MS/MS, tandem MS; PTS domain, proline, threonine and serine domain; TCEP-HCl, tris(2-
carboxyethyl)phosphine-HCl.
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Figure 1 Domain organization of MUC2 and the two CysD fusion constructs
(A) MUC2 is made up of D1-D2-D -D3-CysD-PTS-CysD-PTS (tandem repeated)-D4-B-C-CK
domains. (B) The two CysD fusion constructs named pSMCysD-IgG2a/His and
pSMCysD(2TR)-IgG2a/His are made up by an N-terminal Myc tag, CysD and a C-terminal
IgG-Fc and His6 tag. The second fusion construct included two repeats (2TR) of the general
tandem repeat of the PTS domain. Both fusion proteins included an EK-cleavage site. (C and
D) Analysis of Protein G-puriﬁed CysD–IgG fusion protein by SDS/PAGE and Western blotting
under reducing (Red) and non-reducing (NonRed) conditions before (−)a n da f t e r(+)E K
cleavage. M, molecular-mass standards in kDa. The anti-Myc tag antibody labelled the CysD
part, whereas the BαMIgG antibody recognized the IgG part. Silver, Silver staining.
were constructed, in which the CysD domain alone or including
two copies of the general tandem repeat from the PTS domain
was fused to a removable IgG-Fc region. The two fusion proteins
expressed in CHO (Chinese-hamster ovary) cells were secreted
intotheculturemedium.Thepuriﬁedfusionproteinswerestudied
by gel ﬁltration, and denaturing and native gel electrophoresis,
and the disulﬁde bond pattern was established by MS. The CysD
part formed pH-independent non-covalent dimers stabilized by
intramolecular disulﬁde bonds.
EXPERIMENTAL
Construction of expression vector pSMCysD-IgG2a/His and
pSMCysD(2TR)-IgG2a/His
A PCR product termed EK (enterokinase)-IgG2a/His was gen-
erated from pcDNA3/MUC1-IgG [21] using primers 5
 -CGTC-
TAGAGGATCCGATGATGATGATAAAGCAGAGC-3
  and
5
 -CGTCGCTAGCATGATGGTGATGGTGATGGTAG-3
 .T h i s
encoded XbaI and NheI sites, an EK-cleavage site, exons 1–3
of the murine IgG2a Fc domain and a C-terminal histidine
tag. This amplicon inserted into XbaI and NheI sites of pSM
vector [12] encoding a N-terminal mouse Ig κ-chain signal
sequence and a Myc tag was named pSM-IgG2a/His. The CysD
domain was ampliﬁed from cDNA made from mRNA of LS174T
cells of human MUC2 with primers 5
 -GACTAGTGCTAGCC-
CATGCGTGCCTCTCTGC-3
  and 5
 -GGTCTAGAGTTCTCT-
GTGGTGGTGGTTGTCATG-3
 . This amplicon encoding XbaI
and NheI sites, the second CysD of human MUC2 (bases
5368–5703) and a N-terminal part of the adjacent PTS domain
(bases 5661–5703) was inserted in-frame into the XbaI site of
pSM-IgG2a/His and was called pSMCysD-IgG2a/His.
The annealed phosphorylated primer pair with primers 5
 -GC-
TAGCCCAACAACGACACCCATCAGCACCACCACCATGG-
TGACCCCAACCCCAACACCCACTGGAACACAGACCT-3
 
and 5
 -GCTAGAGGTCTGTGTTCCAGTGGGTGTTGGGGT
TGGGGTCACCATGGTGGTGGTGCTGATGGGTGTCGTTG
TTGGG-3
  encoding the general tandem repeat of the PTS
domain of human MUC2 was inserted sequentially twice
in-frame into the XbaI site of pSMCysD-IgG2a/His and was
called pSMCysD(2TR)-IgG2a/His.
Expression of CysD–IgG and CysD(2TR)–IgG
CHO-K1 and CHO-K1 Lec 3.2.8.1 [22] cells grown in
10% FBS (fetal bovine serum) IMDM (Iscove’s modiﬁed
Dulbecco’s medium; Lonza) with 1% penicillin/streptomycin
were transfected with pSMCysD-IgG2a/His or pSMCysD(2TR)-
IgG2a/His using Lipofectamine
TM 2000 (Invitrogen) and stable
clones were generated 2–3 days later by adding 250 μg/ml
Geneticin (Invitrogen). Clones were selected based on high
secretion of fusion protein into culture medium as described
previously [23]. One high-level expression clone for each
construct was selected, recloned and used for protein production.
Protein production
Adherent CHO-K1 Lec 3.2.8.1 cells producing CysD–IgG were
resuspendedat0.3×10
6 cells/mlin2%FBSProCHO-4medium
(Lonza) with 4 mM L-glutamine, 1×ProHT supplement and
250 μg/ml Geneticin (Gibco). Cells were adapted to serum-free
suspension growth within 6 weeks at 90 rev./min at 37◦Ci n5%
CO2. A 1.5 litre perfusion culture with spin ﬁlter separation
(10 μm) was performed in a 3 litre bioreactor (Applikon)
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controlled by an ADI 1010 Bio Controller and an ADI 1025
Bio Console at 37◦C, pH 6.9, 40% dissolved O2 and 150–
300 rev./min. Oxygen and CO2 were introduced by bubble-free
aeration using 9 m of 1-mm thick silicone tubing. Perfusion rate
was 0.3–0.8 dilutions/day of culture volume. The CysD(2TR)–
IgG fusion protein was produced in T-175 ﬂask cultures grown in
10% IMDM with 250 μg/ml Geneticin (Invitrogen).
SDS/PAGE, BN-PAGE (blue native PAGE) and Western blotting
SDS/PAGEwasperformedasdescribedpreviously[24].Precision
protein standards (Bio-Rad Laboratories) were used as markers.
Silver staining was carried out as described previously [25].
For LC (liquid chromatography)-ESI (electrospray ionization)
MS/MS (tandem MS) non-reducing SDS gels were stained with
Imperial Protein Stain (Thermo Scientiﬁc). Western blotting
was performed as described previously [26]. After transfer the
membrane was blocked in 5% skimmed milk powder in PBS
with 0.1% Tween 20 or in 10 mM Tris/HCl (pH 7.5), 1%
BSA, 100 mM NaCl, 0.1% Tween 20 and 0.05% sodium
azide (for biotin-labelled antibody) and incubated with an anti-
Myc mAb (monoclonal antibody) (clone 9E10.2, American
Type Culture Collection, CRL-1729) or biotin-labelled rat anti-
mouseIgG2a(R19–15,BDBiosciences).Theanti-MycmAbwas
cultured by the Mammalian Protein Expression core facility at
the University of Gothenburg. The membrane was then treated
with AP (alkaline phosphatase)-conjugated goat anti-mouse
IgG1 (Southern Biotech) or streptavidin (Southern Biotech) and
developed with NBT (Nitro Blue Tetrazolium)/BCIP (5-bromo-
4-chloroindol-3-yl phosphate) (Promega).
BN-PAGE allows studies of proteins under native conditions
[27]. BN-PAGE was performed as described previously [27]
on ready-made NativePAGE
TM Novex® 4–16% BisTris
Gels (Invitrogen). NativeMark
TM Unstained Protein Standards
(Invitrogen) were used as markers. BN gels were stained using
silver [25].
Protein G puriﬁcation of CysD–IgG, CysD(2TR)–IgG or EK-cleaved
CysD–IgG
Spent culture medium (9.5 litres) containing CysD–IgG fusion
protein was ﬁltered (0.45 μm Mini Capsule, PALL) and
concentrated by Tangential Flow Filtration (Pellicon
TM-2 system,
Millipore) with two 5 kDa PLCC ﬁlters (four times in 1 litre
of PBS reduced to 500 ml). For Protein G puriﬁcation
of CysD(2TR)–IgG fusion protein, serum-containing medium
(130 ml) was dialysed (Spectra/Por® Dialysis Membrane, mole-
cular-mass cut-off of 6–8 kDa, Spectrum Laboratories) three
times against 20 mM sodium phosphate buffer (pH 7) and ﬁltered
(Durapore® Membrane Filter, 0.22 μm GVWP, Millipore). The
concentrate or ﬁltered medium was loaded on to a HiTrap
Protein G HP column (1.6 cm×2.5 cm, Amersham Biosciences)
equilibrated with 20 mM sodium phosphate buffer (pH 7) at
1 ml/min. The column was rinsed with the same buffer.
Bound components were eluted [100 mM glycine/HCl (pH 2.7)],
collected in 1-ml neutralized fractions [100 mM Tris/HCl (pH 9)]
and analysed by SDS/PAGE and silver staining. EK-cleaved
CysD–IgG was directly loaded on to a Protein G column and
the ﬂow-through and eluate fractions were analysed.
Sialidase and EK treatment
Puriﬁed CysD–IgG and CysD(2TR)–IgG fusion proteins were
cleaved with EKMax
TM for 15 h at 37◦C in EKMax
TM Reaction
Buffer [50 mM Tris/HCl (pH 8.0), 1 mM CaCl2 and 0.1% Tween
20(Invitrogen)]at1:100(enzyme/substrateratio)andthereaction
was stopped with 2 mM PMSF. The CysD(2TR)–IgG fusion
proteinwastreatedwithsialidase[1:100(Sigma)]andEK-cleaved
(1:100) for 18 h at 37◦C in 50 mM sodium phosphate buffer
(pH 6.0). Desialylated and/or EK-cleaved samples were analysed
by gel ﬁltration, SDS/PAGE and BN-PAGE.
Gel ﬁltration
Puriﬁed CysD–IgG, CysD, IgG or sialylated and desialylated
EK-cleaved CysD(2TR)–IgG fusion protein (5 μg of each) was
applied to a Superose 6 or Superose 12 PC 3.2/30 column
(Amersham Biosciences) and eluted at 0.02 ml/min using an
Ettan system (Amersham Biosciences) with UV absorbance at
215 nm, 254 nm and 280 nm. Standards were chromatographed
atpH 7(50 mMphosphatebufferand150 mMNaCl).Thepuriﬁed
CysD–IgG and CysD(2TR)–IgG (EK- or sialidase-treated) were
eitherdirectlyinjectedorwerebuffer-exchangedbyultraﬁltration
(10000 g at 4◦C; Vivaspin 6 PES, molecular-mass cut-off of
10 kDa, Sartorius) to pH 5.2 (100 mM acetic acid), pH 7 (50 mM
phosphate buffer), pH 7.4 (100 mM Hepes) or pH 8.3 (100 mM
sodium bicarbonate) containing 150 mM NaCl with or without
50 mM CaCl2. The CysD-containing (ﬂow-through) or IgG-
containing(eluate)proteinpartsisolatedbyProteinGpuriﬁcation
ofEK-treatedfusionproteinwereeitherdirectlyinjectedorbuffer-
exchanged by ultraﬁltration (10000 g at 4◦C ;V i v a s p i n6P E S ,
molecular-mass cut-off of 10 kDa, Sartorius) to pH 5 (20 mM
acetic acid), pH 6 (20 mM Mes), pH 7 (20 mM Tris/HCl), pH 7.4
(10 mM phosphate buffer) or pH 8 (20 mM Tris/HCl) containing
150 mM NaCl and 5 mM EDTA or 10 mM CaCl2.
LC-ESI MS/MS, in-gel digestion and MS data analysis
CysD–IgG- and CysD(2TR)–IgG-containing bands excised from
non-reducing SDS gels were destained [three times in 50%
acetonitrile and 25 mM Tris/HCl (pH 7.8)], dried and digested
with Asp-N [0.01 μg/μl in 25 mM Tris/HCl (pH 7.8) (Roche)].
Peptides were extracted and partly dried by centrifugation under
vacuum. The digest of one sample per condition was reduced
{50 mM TCEP-HCl [tris(2-carboxyethyl)phosphine-HCl]} after
which the peptides from both conditions were extracted using
C18 ZipTips (Millipore), eluted (60% acetonitrile, 40% H2Oa n d
0.2% triﬂuoroacetic acid), partly dried and solubilized (0.2%
formic acid). Samples were analysed by LC-ESI MS/MS (LTQ
Orbitrap XL, Thermo Scientiﬁc). Sample injection and LC were
performed as described previously [28]. Data were acquired in a
data-dependent mode automatically switching between MS and
MS/MS acquisition. MS scans were obtained in the Orbitrap
at m/z 400–2000, two microscans, maximum 500 ms injection
and an AGC (automatic gain control) of 500000. MS/MS
was performed in linear ion-trap on the six most abundant
multiple charged ions for each scan (one microscan, maximum
200 ms injection and an AGC of 30000) using CID (collision-
induced dissociation) fragmentation at 30% normalized collision
energy. After fragmentation, peptides were excluded for 10 s
for further acquisition. Peaklists were generated from raw data
using extract_msn.exe (Thermo Scientiﬁc). Data were interpreted
using Mascot (version 2.2, Matrix Science) searched against
IPI human database (version 3.52) with addition of the CysD–
IgG or CysD(2TR)–IgG fusion construct. A second search was
performed against a speciﬁc cross-linked database generated for
CysD–IgG or Cys(2TR)–IgG using xComb (version 1.1) [29].
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Search parameters for reduced samples against IPI human were
as follows: (i) one missed cleavage Asp-N; (ii) tolerance 5 p.p.m.
(precursor), 0.5 Da (fragment ions); (iii) charge state 2
+,3
+,
4
+; and (iv) oxidation cysteine, methionine (variable). Search
parameters for non-reduced samples were as follows: (i) ‘do not
cleave’ after amino acid ‘J’ for non-cleavage; (ii) tolerance 5
p.p.m. (precursor), 0.5 Da (fragment ions); (iii) charge state 2
+,
3
+,4
+; and (iv) dehydro cysteine (ﬁxed), oxidation methionine
(variable), gain of water asparatate (variable). The Mascot cut-off
score was set to 25.
RESULTS
Construction and expression of a recombinant CysD–IgG fusion
protein
A plasmid expressing a Myc tag, the second CysD of human
MUC2 (residues 1782–1878; [4]), an EK-cleavage site, exons 1–
3 of the murine IgG-Fc region and a C-terminal histidine tag was
constructed and called pSMCysD-IgG2a/His (Figure 1B). Fusion
of the CysD domain to IgG was chosen as this gives high protein
expression. The CysD domain contains 97 amino acids and lies
between the small and large PTS domains of human MUC2. The
plasmid was transfected into CHO-K1 Lec 3.2.8.1 cells [22].
Stable clones were generated and selected for the secretion of
maximum levels of CysD–IgG, as determined by immunoassay
[23] and Western blotting (results not shown). One high-level
expression clone was selected and adapted to suspension culture
in protein-free medium.
Puriﬁcation of the CysD–IgG fusion protein
To obtain the CysD–IgG fusion protein, the supernatant from
a perfusion culture was concentrated by ultraﬁltration and then
loaded on to a Protein G column. The bound proteins were eluted
and fractions were analysed by SDS/PAGE and silver stained
(Figures 1C and 1D). The fusion protein migrated at ∼50 kDa
under reducing conditions (Figure 1C, −EK) and at ∼150 kDa
under non-reducing conditions on SDS gels corresponding to
the CysD–IgG monomer and dimer respectively (Figure 1D,
−EK). To separate the CysD from IgG, the fusion protein
was cleaved with EK. The IgG part showed a ∼30 kDa band
under reducing conditions (Figure 1C, +EK) and a dimeric
∼60 kDa band under non-reducing conditions that were both
labelled by the IgG-speciﬁc antibody (Figure 1D, +EK). Three
distinct bands of ∼20–22 kDa were found under reducing
SDS/PAGE that were identiﬁed as the CysD part with the anti-
Myc tag antibody (Figure 1C, +EK). When the EK-cleaved
samples were analysed by non-reducing SDS/PAGE most of the
CysD-containing material disappeared (Figure 1D, +EK). The
disappearanceoftheCysDproteinundernon-reducingconditions
on SDS-treated samples led us to speculate that it had a high
tendency to form insoluble aggregates and the CysD was studied
further under native conditions.
Gel ﬁltration and BN-PAGE of the CysD–IgG fusion protein
Theintactfusionproteindisplayedfourmajorbandsat∼200 kDa,
∼400 kDa, ∼600 kDa and ∼800 kDa for the tetra-, octa-,
dodeca- and hexadeca-mers respectively, on silver-stained BN
gels (Figure 2A, −EK). The same material analysed in reducing
SDS gels gave single bands of ∼50 kDa (Figure 1C, −EK).
The EK-cleaved fusion protein showed two strong bands of
∼35 kDa for the CysD dimer and ∼120–180 kDa for the IgG2
Figure 2 BN-PAGE of puriﬁed CysD–IgG fusion protein
(A) BN gel of puriﬁed fusion protein before (−)a n da f t e r(+) EK cleavage. (B) EK-cleaved
fusionproteinwasloadedontoaProteinGcolumnandtheﬂow-throughandeluatewasanalysed
by BN-PAGE. M, molecular-mass standards in kDa. The gel lanes, including standards, shown
together come from the same gel.
dimer respectively, in BN gels (Figure 2A, +EK). Next, EK-
c l e a v e df u s i o np r o t e i nw a sl o a d e do nt oaP r o t e i nGc o l u m n
and analysed by BN-PAGE. The CysD fusion part found in the
ﬂow-through migrated as a ∼35 kDa CysD dimer on BN gels
as the calculated CysD monomeric mass is 16 kDa (Figure 2B,
Flow through). When the IgG-containing eluate was separated
on native gels, three bands of ∼120–180 kDa, ∼200 kDa and
∼400 kDa respectively, were found (Figure 2B, Eluate), the ﬁrst
band due to dimeric IgG that was cleaved from its fusion partner,
and the two latter ones due to oligomeric forms of remaining
non-cleaved fusion protein.
Gelﬁltrationwasthenusedtofurtherinvestigatetheoligomeric
state of CysD and its fusion protein. The CysD–IgG fusion
protein eluted as two major peaks at ∼200 kDa and ∼800 kDa
respectively(Figure3A).Thissuggeststhehigheroligomerictetra
and hexadeca forms as observed on the native gels as analysis
of these two peaks on reducing SDS gels showed the expected
∼50 kDa CysD–IgG band in both peaks. When the IgG part
was analysed by gel ﬁltration, a single peak eluted at ∼35 kDa
(Figure 3B). Reducing SDS/PAGE and silver staining conﬁrmed
thepresenceofthe∼30 kDaIgGform.TheCysDproteinelutedat
30 kDa suggesting a dimeric form as it migrated with an apparent
mass of 20–22 kDa on reducing SDS gels (Figure 3C).
Gel ﬁltration of CysD(2TR)–IgG fusion protein
To further prove the dimeric nature of the CysD domain and that
this was not caused by the absence of a ﬂanking mucin domain
with a typical glycosylation, a second fusion protein with two
human MUC2 tandem repeats (23 amino acids each) were also
analysed (Figures 1A and 1B). The plasmid pSMCysD(2TR)-
IgG2a/His was transfected into CHO-K1 cells which give normal
sialylated N-glycans and largely sialyl-T O-glycans (NeuAcα2–
3Galβ1–3GalNAc-) [21]. One high-level expression clone was
selected for protein production. The Protein G-puriﬁed fusion
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Figure 3 Gel ﬁltration of the CysD–IgG fusion protein
(A) Puriﬁed fusion protein was analysed on a Superose 6 gel-ﬁltration column. The Superose
6 column had a void volume of 0.843ml, and the standards thyroglobulin (669kDa), ferritin
(440kDa), aldolase (158kDa) and ovalbumin (43kDa) eluted at 1.315ml, 1.494ml, 1.629ml
and 1.753ml respectively. (B and C) EK-cleaved fusion protein was loaded on to a Protein
G column and the bound material (B) and ﬂow-through (C) were analysed on a Superose 12
gel-ﬁltrationcolumn.TheSuperose12columnhadavoidvolumeof0.831ml,andthestandards
aldolase (158kDa), conalbumin (75kDa), ovalbumin (43kDa) and ribonuclease A (13.7kDa)
elutedat1.236ml,1.315ml,1.382mland1.584mlrespectively.UVabsorbanceunitsaregiven
inmAU.Thecontentofcollectedfractionsfrommajorpeaks(indicatedbyarrows)wasanalysed
on reducing SDS gels (shown as insets) with silver staining. M, molecular-mass standards in
kDa. The gel lanes shown together come from the same gel.
protein migrated at ∼75 kDa on a reducing SDS gel (results not
shown). The IgG part of the EK-cleaved fusion protein showed as
fortheﬁrstproteina∼30 kDabandunderreducinganda∼60 kDa
band under non-reducing SDS/PAGE (Figure 4A). Three distinct
bandsof∼40–45 kDaowingtotheCysD(2TR)partwerelabelled
bytheMyctagantibodyinareducingSDSgel(Figure4A).When
the same EK-cleaved material was analysed under non-reducing
SDS/PAGE, most of the CysD-containing material was absent as
before (Figure 4A). The EK-cleaved fusion protein eluted from
a gel-ﬁltration column as two distinct peaks at ∼113 kDa and
∼35 kDa respectively. The 113 kDa peak was due to dimeric
CysD(2TR), whereas the 35 kDa protein form was due to IgG
as conﬁrmed by SDS/PAGE and Western blotting (Figure 4B,
−sialidase). Desialylation had no inﬂuence on the elution time
of the IgG part from the gel-ﬁltration column or migration
behaviour in reducing and non-reducing gels (Figures 4A and
4B). Desialylated dimeric CysD eluted at ∼95 kDa from the
gel-ﬁltration column (Figure 4B, +sialidase) and migrated as
a monomer at ∼50 kDa, slightly larger than sialylated, when
analysed by reducing SDS/PAGE (Figure 4B, +sialidase). The
sialic acids are probably attached to the N-linked glycans as the
CysD domain of MUC2 contains three potential N-glycosylation
sites and this also explains the presence of three separate bands
on reduced SDS gels when the protein was sialylated. It can thus
be concluded that the CysD had an estimated mass inferred from
gel ﬁltration and BN-PAGE experiments as for a dimer. The IgG
formed covalent dimers and when fused to the CysD that also
formed dimers, larger oligomeric ladders were found. The CysD
dimer were not quantitatively revealed on non-reduced SDS gels,
something that might suggest disulﬁde stabilization. This was not
the case as shown below.
Effect of pH and calcium on the dimeric state of the CysD domain
To reveal whether the CysD dimer was affected by pH and
calcium, recombinant CysD was isolated and analysed by gel
ﬁltration at different pH values in the presence or absence
of calcium. The isolated CysD-containing material eluted as a
30 kDa dimer in buffers at low or high pH (Figure 5A) and when
analysed in the presence or absence of calcium (Figure 5B).
A tiny shift towards a smaller size, less than expected for a
change in oligomeric status, was observed at low pH and high
calcium as for the conditions in the secretory vesicles. Different
pH and calcium conditions were tested to dissociate the 30 kDa
CysD dimers into monomers (described in the Experimental
section), but no conditions were able to do this (results not
shown).
Disulﬁde bond pattern of the CysD domain determined by LC-ESI
MS/MS
To reveal whether the CysD dimers were held together by
disulﬁde bonds, the band of interest containing the CysD–
IgG fusion protein was excised from a non-reducing SDS
gel, in-gel digested with Asp-N and then analysed by LC-ESI
MS/MS and database searching as described previously [29].
All ten cysteine residues of the CysD domain formed ﬁve
intramolecular disulﬁde bonds within four peptides (Figure 6A).
Three unambiguous cysteine pairs were allocated as follows:
Cys
32–Cys
36,C y s
63–Cys
73 and Cys
92–Cys
100 respectively. MS
analysis revealed that the non-cysteine-containing peptide at
m/z 934.96
2+ was partly acetylated at Lys
46. The last peptide
was observed as a triply charged ion at m/z 924.07
3+.T h i s
peptide included the four remaining cysteine residues that formed
two internal disulﬁde bonds as the observed molecular mass
(2769.17 Da) had lost four hydrogen atoms as for two disulﬁde
bonds. There were no fragmentation spectra that could reveal the
exact disulﬁde bond pattern, but the most likely disulﬁde bond
arrangement in this peptide was Cys
116–Cys
126 and Cys
125–Cys
128
respectively.ThepeptideDVPIGQLGQTVVCDVSVGLICKNE,
includinganAsp-NcleavagesiteatAsp
93 withintheCys
92–Cys
100
disulﬁde bridge (in bold), eluted as two distinct peaks due to
a partial cleavage at this site (Figure 6B). The ﬁrst peptide at
m/z 835.09
3+ eluted at 37.5 min from the column, whereas the
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Figure 4 Analysis of EK-cleaved CysD(2TR)–IgG fusion protein by SDS/PAGE and gel ﬁltration
(A) EK-cleaved CysD(2TR)–IgG fusion protein was analysed by SDS/PAGE and Western blotting under reducing (Red) and non-reducing (NonRed) conditions before (−) and after (+) sialidase
treatment.Thesamematerialasin(A)wasalsoanalysedonaSuperose12gel-ﬁltrationcolumn(B).ElutiontimesofstandardsareasspeciﬁedinthelegendforFigures3(B)and3(C).UVabsorbance
units are given in mAU. The content of collected fractions from major peaks (indicated by arrows) before (−) and after (+) sialidase treatment was analysed by reducing SDS/PAGE and Western
blotting (shown as insets). The anti-Myc tag antibody labelled the CysD(2TR) part, whereas the BαMIgG antibody recognized the IgG part. M, molecular-mass standards in kDa. The gel lanes shown
together come from the same gel.
secondpeptideatm/z1242.63
2+ elutedat52.5 min.Theﬁrstpeak
originated from cleavage at Asp
93 within the loop formed by the
Cys
92–Cys
100 disulﬁde pair. In the second peak, the non-cleaved
formofthesamepeptidewasfoundwithanintactloop.Proteolytic
cleavage within the loop of Cys
92–Cys
100 had a profound effect
on the hydrophobic properties of this peptide, as the elution times
for the two different forms when separated on the hydrophobic
C18 column shifted dramatically upon opening the loop.
In the peptide DLSSPCVPLCNWTGWL at m/z 894.90
2+,
the intramolecular disulﬁde bridge (Cys
32–Cys
36) was still intact
after fragmentation, and peptide sequence information was only
obtained for the neighbouring amino acids that were ﬂanking the
intact cysteine pair (Figure 7A). Upon reduction of the samples
with the reducing agent TCEP-HCl the intact disulﬁde bridge
was chemically cleaved (Figure 7B) and almost complete y
and b ion series were obtained. The WXXW peptide motif in
this peptide was not C-mannosylated as predicted on the ﬁrst
tryptophan residue when analysed in its reduced or non-reduced
form (Figure 7). Thus all disulﬁde pairs were within the CysD
and no indication of any intermolecular disulﬁde bonds could be
found.
DISCUSSION
The function of CysD domains found in gel-forming mucins
has not been understood to date. However, we have been able
to show that the CysD domain of human MUC2 forms non-
covalent dimers. The ∼50 kDa form of the CysD–IgG fusion
protein observed in reducing SDS gels migrated at ∼200 kDa,
∼400 kDa, ∼600 kDa and ∼800 kDa by BN-PAGE, and eluted
at ∼200 kDa and ∼800 kDa by gel ﬁltration due to IgG covalent
and CysD non-covalent dimers. Furthermore, the CysD part with
a calculated mass without glycans of 16 kDa eluted at 30 kDa by
gel ﬁltration and at 35 kDa by BN-PAGE, suggesting that CysD
forms dimers. The Fc region of IgG from mouse is known to form
three intermolecular disulﬁde bridges via residues Cys
237,C y s
240
and Cys
242 respectively, in the hinge core by connecting two IgG
chains to a covalent dimer [30]. In line with this, we observed that
the ∼30 kDa IgG part formed a ∼60 kDa dimer in non-reducing
SDS gels. The dimeric nature of the CysD domain was conﬁrmed
by analysing a second recombinant CysD fusion protein that
included two 23-amino acid-tandem repeats of the MUC2 mucin.
The CysD(2TR) protein formed three bands at ∼40–45 kDa on
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Figure 5 Effect of pH and calcium on the dimeric state of the CysD domain
The CysD-containing fraction of EK-cleaved CysD–IgG fusion protein was analysed on a
Superose 12 gel-ﬁltration column at pH8 and pH5 with 5 mM EDTA (A) or at pH8 with and
without 10mM CaCl2 (B). UV absorbance units are given in mAU. Elution times of standards
are as speciﬁed in the legend for Figures 3(B) and 3(C).
reducingSDSgelsandelutedasa∼113 kDapeakingelﬁltration.
Massdeterminationbygelﬁltrationdependsonthehydrodynamic
(Stokes) radius of the protein and overestimation of mass is not
atypical for glycoproteins [31]. Nevertheless, comparative gel-
ﬁltration analysis of glycoproteins and their desialylated forms
revealed that the apparent molecular masses of desialylated forms
were smaller than expected just from removal of the mass of
sialic acid [32]. Thus the aberrant behaviour of glycoproteins
by gel ﬁltration is largely contributed to by the negative charges
of sialic acids [32]. Desialylated CysD(2TR) protein migrated
at ∼50 kDa in reducing SDS gels and eluted as a ∼95 kDa
peak by gel ﬁltration. These ﬁndings strongly supported that
the CysD domain formed dimers. The three bands of ∼20–
22 kDaofrecombinantCysDand∼40–45 kDaoftheCysD(2TR)
protein respectively, found in reducing SDS gels originated
from differentially sialylated glycoprotein forms. For the latter
protein we showed that the three distinct bands were shifted to
one ∼50 kDa band by sialidase treatment. The sialic acids are
probably attached to the N-linked glycans as the CysD domain of
MUC2 contains three N-glycans.
Perez-Vilar et al. [20] have previously studied two of the CysD
domains in the MUC5AC mucin and they concluded that these
are monomeric. In contrast with [20], we have made quantitative
biochemical analyses at the protein level instead of only using
radioactive traces. Although we have not worked with the same
mucin CysD, we have not found evidence for the conclusions
made by Perez-Vilar et al. [20]. Cross-linking experiments
asreportedbyPerez-Vilaretal.[20]aftersimplepuriﬁcationdoes
not prove that CysD are monomers. In fact, there are substantial
amounts of dimers in their gels.
In conclusion, CysD forms non-covalent dimers and the
∼200 kDa tetrameric complexes of the CysD–IgG2a/His fusion
Figure 6 Analysis of disulﬁde bonds in the CysD domain by LC-ESI MS/MS
(A) Disulﬁde bond pattern in the CysD domain. Underlined numbers indicate cysteine
residues forming intramolecular disulﬁde bonds. Solid horizontal lines indicate unambiguous
disulﬁde bonds, whereas broken horizontal lines indicate theoretical disulﬁde bonds. Solid
vertical lines represent the position of cleavage sites. (B) LC-MS separation of the peptide
DVPIGQLGQTVVCDVSVGLICKNEwithaninternaldisulﬁdebond.Peaknumberonerepresented
theextractedionchromatogramofthepeptidecleavedN-terminaltotheaspartateresidueposition
93. The second peak belonged to the non-cleaved form causing an increase in hydrophobicity.
protein are built up by disulﬁde-bonded IgG dimers that interact
via its fused CysD domain(s) with another identical dimer (Fig-
ure 8A). Further oligomerization (dimerization) of the ∼200 kDa
complexes is mediated via non-occupied free CysD domains
thus forming stable ∼400 kDa octameric (Figure 8B), ∼600 kDa
dodecameric and ∼800 kDa hexadecameric complexes.
To further understand the nature of the CysD dimer and
the bonds formed by the ten cysteine residues in the CysD
domain, we cleaved the CysD–IgG fusion protein with Asp-N
and analysed the peptides by LC-ESI MS/MS. All ten cysteine
residues of the CysD domain were involved in intramolecular
disulﬁde bonds as follows: Cys
32–Cys
36,C y s
63–Cys
73,C y s
92–
Cys
100,C y s
116–Cys
126 and Cys
125–Cys
128 respectively. Although
the exact disulﬁde pattern for the peptide with four cysteine
residues could not be elucidated from the MS data, the disulﬁde
bonds Cys
116–Cys
126 and Cys
125–Cys
128 are most likely. As all
of the ﬁve disulﬁde bonds were pair wise within four peptides
and no other cysteine-containing peptides were found, it can be
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Figure 7 LC-ESI MS/MS analysis of the CysD peptide with a C-mannosylation motif
A CysD-IgG-containing band from a non-reduced SDS gel was excised, in-gel digested with Asp-N and analysed by LC-ESI MS/MS. CID-fragmentation spectra of the CysD peptide
DLSSPCVPLCNWTGWL in (A) with an intact disulﬁde bridge and in (B) after reduction with TCEP-HCl. Both fragmentation spectra showed the absence of C-mannosylation on the ﬁrst
tryptophan residue of the WXXW peptide motif.
concluded that the disulﬁde bonds were intramolecular and that
the CysD dimers were held together with non-disulﬁde bonds.
A high hydrophobicity of the loop generated by the Cys
92–
Cys
100 disulﬁde bridge (CDVSVGLIC) was observed as long
as the loop was intact. This hydrophobicity was much higher
than that of the open peptide itself and a cleavage between the
two cysteine residues (Figure 6B) gave the same loss of hydro-
phobicity as reducing the disulﬁde bond of the intact peptide.
A similar conserved hydrophobic amino acid sequence stretch
between these two cysteine residues can be found in all CysD
domains of gel-forming mucins, indicating that the formation of
a hydrophobic loop at this site is important for the CysD function.
It may be speculated that the ‘disappearance’ of the CysD protein
undernon-reducingconditionsuponSDS/PAGEisduetothis(and
maybe other) hydrophobic patch(es) present in a highly stabilized
globular protein. It is tempting to speculate that the hydrophobic
loop stabilized by the Cys
92–Cys
100 pair is exposed at the surface
ofthemolecule,therebyformingtheverystableCysDdimersthat
were observed by gel ﬁltration. The observation that one of the
lysine residues could be acetylated would make the CysD even
more hydrophobic.
Besides gel-forming mucins, the CysD domain has also been
identiﬁed in the protein Oikosin 1 of the larvacean tunicate
O. dioica [18]. This protein contains 13 tandemly repeated CysD
domains.Larvaceansfeedondissolvedorganiccarbonandmicro-
organisms by ﬁltering seawater through a transparent structure
called the house. Importantly, Oikosin 1 is the major structural
component [18] and is probably involved in the assembly of the
secreted house. Owing to the high number of adjacent tandemly
repeated CysD domains, it may be speculated that they function
in ‘sticking’ the house together.
A potential C-mannosylation WXXW acceptor site [19] is
found in the CysD domains of MUC2, MUC5AC and MUC5B,
and in 11 repeats in Oikosin 1. Although it was postulated based
on mutational studies that at least the CysD1 and CysD5 domains
of MUC5AC are mannosylated [20], we did not ﬁnd such a
modiﬁcation on the tryptophan residue of the WXXW peptide
motif in the peptide DLSSPCVPLCNWTGWL. In our analysis
the tryptophan residue was not modiﬁed as determined by ESI-
MS/MS. Mannosylation is easily identiﬁed by MS [33]. The two
different CysD variants investigated in the present study were
producedinCHO-K1andCHO-K1Lec3.2.8.1cellsrespectively.
Other studies on C-mannosylated proteins have expressed the
protein in the CHO-K1 cell line where the tryptophan residue in
the WXXW peptide motif was modiﬁed [34]. Perez-Vilar et al.
[20] claim CysD mannosylation, something we could not verify,
atleastintheCysDinvestigatedinthepresentstudy.Intheirpaper
[20], indirect experimentation using mutagenesis was done and
no biochemical proof supporting such a conclusion was provided.
ThepHalongthesecretorypathwayshiftsgradually,from7.2in
the endoplasmic reticulum [35], to 6.0 in the trans-Golgi network
[36], to 5.2 in the secretory granules [37] and upon release rises
up to 8.0 in the colon lumen [38]. In addition, mucin packing into
storage granules is accompanied by an increase in intragranular
calcium concentration [39]. Gel-ﬁltration analysis of isolated
CysD dimer indicated that it did not dissociate at different pH
conditions (pH values of 5, 6, 7 or 8) or calcium concentrations
(0, 10 or 50 mM) and is probably due to the hydrophobic nature
of the disulﬁde-bond-stabilized loop. The mucins stored in the
mucus granulae are expanded 1000-fold upon release into
the lumen. It is difﬁcult to envisage how CysD dimers could
exist in the secretory granulae and still allow this large volume
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Figure 8 Proposed model of CysD dimers in the fusion protein and the
MUC2 gel
The CysD–IgG fusion protein is made up of two subunits and each is 50kDa in size. These two
subunitsarecovalentlylinkedviatheIgGFcpart(disulﬁdebridges)andformacovalent100kDa
dimer. (A) Two covalent 100kDa CysD–IgG dimers form a non-covalent 200kDa tetramer via
non-covalent interactions of the CysD domain. (B) Four covalent 100kDa CysD–IgG dimers
formanon-covalent400kDaoctamervianon-covalentinteractionsoftheCysDdomain.Inboth
cases the CysD domains form non-covalent dimers. (C) The MUC2 mucin forms a covalent gel
via its N- and C-terminal domains. The N-terminus of MUC2 forms covalent trimers, whereas
theC-terminusformscovalentdimers.TheCysDdomainformsnon-covalentdimers.TheCysD
domain inserts non-covalent cross-links into the MUC2 gel thereby determining its pore size
and gel properties.
expansion. Although low pH or high calcium conditions do not
dissociate the CysD dimers, it is tempting to speculate that the
CysD domains exist in a momomeric form within the secretory
granules.TheputativemonomericstateoftheCysDdomainsmay
be achieved by a ‘capping’ protein.
As the second CysD domain is localized to the large middle
part of MUC2 ﬂanked by the small and large mucin domains
[4], this CysD domain will insert additional cross-links into the
net-like gel (Figure 8C). Although such a role is theoretical
and based on in vitro experiments of recombinant proteins, it
is tempting to speculate that the CysD may act as a biomolecular
‘glue’ sticking neighbouring polymer chains together. By glueing
adjacentCysDdomainstogethertheoverallporesizeofthemucus
gel meshwork will decrease. Interestingly, the three gel-forming
mucins MUC2 [40], MUC5AC [14] and MUC5B [15] do not
differ in their N-terminal and C-terminal parts, but they differ in
thenumberofCysDdomainsandhowthesearedistributedwithin
thecentralpartofthemolecules.TheMUC2mucinhastwoCysD
domains, whereas MUC5AC has at least nine CysD domains
[14] and MUC5B has seven CysD domains [15], interspersed by
relatively short mucin domains. The MUC2 mucin has one large
mucin domain (approximately 2300 amino acids), which does
not contain any additional CysD domains [4]. As the number
of and the distance between the CysD domains varies among
different gel-forming mucins, gels with different porosity will be
produced.Thissuggests amuchdenserpolymer inMUC5AC and
MUC5BthaninMUC2.WhereasMUC2isthemajorgel-forming
mucin of the intestine [4], MUC5AC and MUC5B are the main
components of secreted mucin in the stomach (only MUC5AC)
and airways [41]. The different expression patterns of MUC2 and
MUC5AC/MUC5B may point to different functions of the gels
formed. Analysis of mouse colonic mucus [10] showed that
it consists of two layers: a densely packed ﬁrm layer devoid
of bacteria and a movable loose layer. As both layers are
mainly composed of Muc2, these ﬁndings indicate a barrier
function of the Muc2 colonic mucus probably controlled by the
pore sizes. However, the MUC2 mucin still needs to have a
relativelylargeporesizeasitshouldstillallownutrientstopassin
the small intestine. In contrast, the mucus of the stomach should
only allow ions to pass and in the lungs only gases. It may thus
be proposed that denser MUC5AC/MUC5B gels are important
for trapping small particles in the lungs before being removed
by the mucociliary system. Interestingly, in a previous review by
Hollingsworth and Swanson [42] it was discussed that the mucus
gel may act like a molecular sieve allowing passage of small
molecules, but excluding large molecules and organisms due to
steric hindrance.
In conclusion, the CysD domain of human MUC2 forms
non-covalent dimers and probably has an important role in the
assembly and properties of a mucus gel. However, additional
biochemical studies are necessary to shed light on the role of the
many CysD domains of other gel-forming mucins.
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